Nanotechnology Databases

Comprehensive databases for nanomaterials, events, products,
companies, research labs, degree programs and publications


Nanobiotechnology and Nanomedicine Companies


(Links listed alphabetically)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All

Showing results 76 - 100 of 277

The company develops nanoparticle-based gene therapies for eye disease.
Chemicell develops and produces innovative bioseparation- gene transfection and detection systems based on magnetic nano- and microparticles.
Chemicon offers molecular biology research tools. Included are mRNA expression analysis assays via RT-PCR and PCR amplication methods for apoptosis, cancer, cytokines, signal transduction, MMPs and ECM using colorimetric or bioluminescent formats
The company develops and sells tools for biomedical research based on nanotechnologies. Our products range from nanoparticles in suspensions to engineered surfaces for applications within stem cell research.
The group is involved in the rapidly developing field of nanobiopharmacy. It focuses on tissue engineering (e.g. scaffolds for cartilage and skin replacement, differentiation of stem cells into chondrocytes), wound healing, gene therapy and targeted drug delivery (using above mentioned polysaccharides and their conjugates). The research and innovation is an integral part of the company activities. Due to recent investments in the state-of-the art laboratory equipment and experienced and motivated scientists the company creates a unique center for regenerative medicine research, including various in-vitro and in-vivo tests.
Developed a technology to compact DNA into complexes containing only a single molecule of DNA, resulting in a volume 30-1000 times smaller than other complexes. This simple difference makes Copernicus' "DNA nanoparticles" highly stable and uniquely able to deliver DNA to the nuclei of non-dividing human cells - which includes most cells in the body.
Develops the Emulsiphan™ nanoparticle tumor targeting technology.
Covaris, Inc. is a life science instrument company. Its proprietary instrument platform, based on patented Adaptive Focused Acoustic (AFA) technology brings unsurpassed speed and efficiency to biological and chemical sample preparation. The AFA process, based on shock wave physics, delivers controlled, precise and accurate energy to biological and chemical samples.
Curiox is a bioinstrumentation company enabling the miniaturization of heterogeneous bioassay for researchers working in life sciences, drug discovery, and diagnostics. Curiox's patented miniaturization platform, DropArray, provides up to 1,000 times savings in sample and reagent consumption, and up to 10 times reduction in assay time.
The Company is developing a pipeline of multifunctional, next-generation therapeutics, binding known anti-cancer agents to its patented colloidal gold tumor-targeting nanotechnology.
Cytocentrics AG is a biotechnology company applying its ion channel expertise to support the pharmaceutical industry in the drug discovery process.
CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening. The company develops, manufactures, and distributes products that make cellular analysis robust and reliable by drastically decreasing cell variability.
One of the company's delivery systems in the most advanced stages of clinical development is a novel drug delivery system for Paclitaxel. Because of the better safety and pharmacokinetic profile, the polymeric nanoparticle delivery system is seen as a potential super generic.
Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates.
Applies nanotechnology to the design and manufacture of pumps, coatings and micro-needle arrays.
Deerac Fluidics is a global leader in microlitre and nanolitre liquid handling systems for the Life Sciences industry.
Delpor develops the next generation Drug Delivery Systems that improve the clinical and commercial value of drugs and biopharmaceuticals. The company also has developed a microfabricated nanopore device for the sustained release of therapeutic agents.
The company's NLP technology produces a generation of particles which retains the strength of the Dermazone Solutions' (SDMC) technologies, but includes the ability to produce particles of 60 nanometers to 150 nanometers which are optically clear. The use of this generation of lipid-based particle delivery system provides the ability to control the size of the final particle by controlling the number of NLPs used to assemble the finished particle. This system maintains very high loading capacity of passenger molecules and uses only safe, all natural ingredients to form both the NLPs and the final delivery system.
DiagnoCure has specialized in the development, production and commercialization of molecular diagnostics for the detection and management of cancer
Digilab offers a wide range of sample preparation and liquid handling tool, and a imaging and spectroscopy products for sample identification for the Life Science, Analytical Chemistry and Diagnostic markets.
A specialized biomedical instrument designer, manufacturer, sales and consulting company.
Dune Sciences is an emerging technology company specializing in products and services that will facilitate the development and commercialization of nano-enabled products. The company employs several patented and patent-pending technologies to engineer interfaces for the integration of new materials and devices in medicine, bionanotechnology, energy technologies, and nanoscience.
The company's proprietary NanoCrystal® technology can enable formulation and improve compound activity and final product characteristics for poorly water-soluble compounds.
Endomagnetics was founded to solve healthcare challenges through the application of advanced magnetic sensing technology.
The company's mission is to develop and license R&D projects in Nanotechnology applied to Life Sciences. Endor is also developing pioneer in-house projects in novel Nanomaterials.
left arrowBack to Nanotechnology Links Directory